Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Aliskiren in Healthy Chinese Subjects: A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled Study

By Hu Pei  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 221-228

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension

By Na Yanqun  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 29-39

Adis International

Access to resources Recommend Favorite

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up

By O'Connor Brian J   Kilfeather Stephen   Cheung David   Kafé Henri   Blagden Mark D   Schlösser Noël   Ayres Jon G   Weber Hans-Jochen   Engelstätter Renate  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2791-2803

Informa Healthcare

Access to resources Recommend Favorite

Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology: A Randomized, Double-Blind, Parallel-Group, Placebo- and Moxifloxacin-Controlled, Single-Centre Study

By Matz Jørgen  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 799-811

Adis International

Access to resources Recommend Favorite

Prophylactic Effectiveness of Tobramycin-Dexamethasone Eye Drops Compared with Tobramycin/Vehicle Eye Drops in Controlling Post-Surgical Inflammation in Cataract Patients: Prospective, Randomised, Double-Masked, Two-Arm, Parallel-Group, Placebo-Controlled, Multicentre Study

By Ricardo Notivol  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 523-533

Adis International

Access to resources Recommend Favorite